SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.

Ye, Mu; Wang, Sheng; Qie, Jing-Bo; Sun, Pei-Long

Ye, Mu; Wang, Sheng; Qie, Jing-Bo; Sun, Pei-Long.

Afiliación

Ye M; Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Wang S; Department of General Surgery, Jinshan Hospital, Fudan University, Shanghai, China.
Qie JB; Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Sun PL; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

Front Oncol ; 11: 765484, 2021.

Article en En | MEDLINE | ID: mdl-34671565

Palabras clave

SPRY4-AS1; biomarker; enhancer RNA; hepatocellular carcinoma; therapeutic target

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google